Scientific Program

23 February 2018

As of 12 Sep 2017

The 13th International Conference of the Asian Clinical Oncology Society (ACOS 2018)
23-25 February 2018 Chiang Mai, Thailand

Friday 23 February 2018
8.30-9.00 Opening Ceremony
9.00-09.45 Keynote lecture 1
Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.
Speaker: Yeul Hong Kim
Moderators:  
Kannika Phornphutkul, Tsang-Wu Liu
09.45-10.15 Coffee Break/ Exhibition/ Poster Session
10.15-11.00 Plenary Session 1
What is new in colorectal cancer treatment?
Speaker: TBA from MD Anderson Cancer Center
Moderators: Arkom Cheirsilpa, Sanjeev Misra
11.00-12.00 Industry Supported Symposium 1
Roche
12.00-12.15 Intermission
12.15-13.00 Industry Supported Symposium 2
Pfizer
13.15-14.00 Keynote lecture 2
Treatment of HCC in 2018
Speaker: Masatoshi  Kudo
Moderators:
Narongsak Kiatikajornthada,  Dinesh Chandra Doval
14.00-15.00

Invited Session 1
Colorectal

Invited Session 2
Breast
Invited Session 3
Cancer screening and prevention
Invited Session 4
GU

Genomic-Molecular Landscape in Colorectal Cancer

  • Pathologist perspective
  • Surgical Oncologist perspective
  • Medical Oncologist
Optimal treatment of Metastatic Breast Cancer

  • Hormonal positive Breast Cancer
  • Triple Negative Breast Cancer
  • Her-2 positive Breast Cancer 2017

Technical details of EBUS
Lung Cancer Screening
Tobacco Cessation

Multidisciplinary management of muscle-invasive bladder cancer

  • Urologist
  • Medical oncologist
  • Radiation oncologist

 

15.00-15.30 Coffee Break/ Exhibition/ Poster Session
15.30-16.30 Invited Session 5
Bone Sarcoma
Invited Session 6
Non Colorectal
Invited Session 7
Thyroid
Invited Session 8
GU
Systemic therapy in Osteosarcoma

Germline and samotic genetics of osteosarcoma

Precision treatment in osteosarcoma

Update Guideline and Management for gastric cancer in Asia

“Multimodality treatment aspect for advance gastric cancer in Thailand”

  • Surgeon perspective
  • Medical oncology perspective
  • West and East debate and guideline update
Treatment strategies for radioactive iodine-refractory, progressive differentiated thyroid cancer

  • Nuclear Medicine perspective:
  • Medical Oncology perspective:
  • Supportive care and management of side effects of targeted therapy in a Thyroid cancer :
Prostate cancer:

  • Role of MP MRI in Prostate
  • State-of-art in sequencing treatment of metastatic castration refractory prostate cancer
16.30-17.30 Industry Supported Symposium 3
18.00-20.00 Faculty Dinner (By Invitation Only)

Remark
Symposium time will be referred to the sponsor package benefit
60 minutes
45 minutes
45 minutes
45 minutes

24 February 2018

As of 12 Sep 2017

The 13th International Conference of the Asian Clinical Oncology Society (ACOS 2018)
23-25 February 2018 Chiang Mai, Thailand

Saturday 24 February 2018
07.30-08.15 Industry Supported Symposium 4
Eli Lilly
08.15-09.00 Plenary Session 2
Breast cancer outlook for 2018
Speaker: Martine Piccart
Moderators:
Jae Kyung Roh, Shigetoyo Saji
09.00-09.45 Coffee Break/ Exhibition/ Poster Session (Tea symposium)
Amgen
09.45-10.30 Keynote lecture 3
New stage of the Companion Diagnostics.
Speaker: Yasushi Yatabe
Moderators:  Nirush Lertparasertsuke,  Yuan-kai Shi
10.30-11.30 Invited Session 9
Pancreas
Invited Session 10
Head and Neck
Invited Session 11
Gyne
Invited Session 12
Immunotherapy
Multidisciplinary approach for locally advance pancreatic head cancer
Speaker:

  • How far for aggressive surgical treatment:
  • Can we improve treatment outcome by radiotherapy?:
  • Update of pre-and post-operative systemic treatment:
Advanced surgery for head and neck cancer

Speaker:  Kodaganur S. Gopinath
Personalized medicine in head and neck cancer

Metastasis to gynecologic tract: How to specify primary site?
Case Discussion

  • Gynecologist Perspective:
  • Pathologist Perspective:
  • Radiologist Perspective:
  • Does immunotherapy cure advanced cancer?
  • Predictive biomarkers for immunotherapy
  • Practical management of toxicities of immunotherapy
11.30-12.30 Industry Supported Symposium 5
TTY Biopharm
12.30-12.45 Intermission
12.45-13.30 Industry Supported Symposium 6
Astrazeneca
“PARP inhibition: Strategic approaching for BRCAm Ovarian Cancer”

Speaker : John Whay-Kuang Chia
Moderator : Prapaporn Suprasert
13.45-14.45 Invited Session 13
Breast
Invited Session 14
Soft Tissue Sarcoma & GIST
Invited Session 15
Gyne
Invited Session 16
Pharmaco
  • Treatment of young women with breast cancer
  • Breast Reconstruction
Management of GIST

Understanding Sarcoma Tumors

Systemic treatment of Soft Tissue Sarcoma

Chemotherapy in gynecologic cancer: Asian view

  • Endometrial cancer
  • Ovarian cancer: See Hui Ti
  • Cervical cancer
Drug development in Thailand

Genetic Polymorphisms of relevance to management of East Asians with Cancer

Accessibility of high cost drug in Asia

14.45-15.15 Coffee Break/ Exhibition/ Poster Session
15.15-16.15 Abstract
Session 1
Abstract
Session 2
Abstract
Session 3
Abstract
Session 4
16.15-17.15 Invited Session 17
Imaging
Invited Session 18
Supportive care
Invited Session 19
Lung
Invited Session 20
HCC
 PET in oncology and CMU experience: 

Speaker:

  • CMU experience:
  • BDMS experience:
  • New paradigm of PET study in oncology:
 Symptom control in cancer patients

Speaker:

  • Dyspnea treatment
  • Pain management
  • Alternative medicine: role of acupuncture
Adjuvant EGFR in Lung cancer
Speaker: Yi Long WuManagement of N2 diseaseProton therapy in Lung Cancer:
Case discussion:  Multidisciplinary approach for HCC

Speaker:

  • Liver surgeon
  • Intervention radiologist
  • Radiation therapist
  • Medical Oncologist
17.15-18.00 Industry Supported Symposium 7
19.00-21.00 Gala Dinner


Remark
Symposium time will be referred to the sponsor package benefit
60 minutes
45 minutes
45 minutes
45 minutes

25 February 2018

As of 12 Sep 2017

The 13th International Conference of the Asian Clinical Oncology Society (ACOS 2018)
23-25 February 2018 Chiang Mai, Thailand

Sunday 25 February 2018
07.45-08.30 Industry Supported Symposium 8
MSD
08.30-09.30 Invited Session 21
Lung
Invited Session 22
Colorectal
Invited Session 23
NET
Invited Session 24
Colorectal
  • VATS for Lung Cancer
  • Malignant pleural effusion
  • Mediastinal germ cell
  • Thymic Carcinoma
Case Discussion

  • Colorectal cancer with Lung Metastasis
  • Colorectal cancer with Liver Metastasis
Pathological diagnosis of Neuroendocrine CA Lung

Treatment of SCLC

Treatment of Large cell Neuroendocrine CA

Multidisciplinary approach for locally advanced rectal cancer

Speaker:

  • Surgeon perspective
  • Medical Oncologist perspective
  • Radiation oncologist perspectives
09.30-10.15 Plenary Session 3
Personalized, genotype-directed therapy for advanced non-small cell lung cancer
Speaker: Solange Peters
Moderator : TBA
10.15-10.45 Coffee Break/ Exhibition/ Poster Session
10.45-11.45 Abstract & Poster Discussion Abstract & Poster Discussion
11.45-12.45 Industry Supported Symposium 9
MSD
13.00-14.00 Keynote lecture 4:
Soft tissue Sarcoma
Speaker: TBA from MD Anderson Cancer Center
Moderator : TBA
14.00-15.00 Invited Session 25
Lung
Invited Session 26
Breast
Invited Session 27
Imaging
Invited Session 28
Non Colorectal
Metastatic lung cancer

Speaker:

  • Targeted Therapy in Advanced NSLC (EGFR):
  • Targeted Therapy in Advanced NSCLC (ALK & ROS 1):
  • Immunotherapy in Lung CA: Solange Peters
Immunotherapy in breast cancer

Understanding genomic rearrangement in breast cancer
Speaker: Aubrey Thompson

Emerging Research Strategies in Breast Cancer

Management of Lung Squamous Cell Carcinoma

Tumor Mutation Load as Predictive Marker for cancer Immunotherapy

Liquid Biopsy a step forward towards precision medicine

Multi-disciplinary approach for locally advanced gastric cancer

  • Molecular genetic study and biomarker in Asia and integrative management of locally advance stage
  • Metastatic stage: How to approach?
15.00 Adjourn


Remark
Symposium time will be referred to the sponsor package benefit
60 minutes
45 minutes
45 minutes
45 minutes

Highlight topics

• Immunotherapy
• Targeted Therapies
• Biomarker
• Molecular pathology
• Precision Medicine